Navigation Links
Lack of patient-provider discussion contributes to disparities in use of breast reconstruction
Date:4/2/2008

CHICAGO (April 2, 2008) In a new study examining disparities in postmastectomy breast reconstruction, researchers at Brigham and Womens Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) in Boston, Mass., concluded that lack of patient-provider discussion may contribute to socioeconomic, age and race-related inconsistencies in the use of breast reconstruction after mastectomy. However, the study also found that reconstruction was more likely to occur after the surgeon discussed options with the patient, suggesting that efforts are required to increase and improve these conversations. The full study appears in the April issue of the Journal of the American College of Surgeons.

Breast reconstructive surgery is an expensive elective procedure, but for many women it is a vital component of surgical care for breast cancer. The choice to have breast reconstruction is a complex decision that is influenced by access to care, patient preference and the providers interaction with the patient.

Patient preferences should be respected, but an informative discussion of reconstruction is required to help patients understand and weigh the risks and benefits of this procedure, said Caprice C. Greenberg, MD, Instructor of Surgery in the Center for Surgery and Public Health at BWH and the Center for Outcomes and Policy Research at DFCI. We learned that physicians need to improve communications with patients and whenever possible, universally address the issue of reconstruction with all women undergoing a mastectomy, regardless of age, race or socioeconomic status.

Using the National Initiative on Cancer Care Quality database, researchers evaluated 626 patients who underwent mastectomy for breast cancer. The data had been collected in a study commissioned by the American Society of Clinical Oncology (ASCO) and undertaken by researchers at the Rand Corporation and the Harvard School of Public Health. Researchers reviewed data collected via survey and chart review approximately four years after diagnosis of breast cancer. Of these patients, 253 (40.4 percent) received breast reconstruction, and 249 (39.8 percent) had medical records documenting the occurrence of a discussion about this option.

The data from the NICCQ study are continuing to reveal important opportunities to improve cancer care, said ASCO President Nancy Davidson, MD, professor of oncology and breast cancer research chair at the Sidney Kimmel Cancer Center at Johns Hopkins University in Baltimore. As oncologists, we need to be sure that we are thoroughly communicating with patients about all of their options for care.

Approximately 70 percent of patients who had a documented discussion about breast reconstruction with their provider underwent the procedure. However, researchers found that increasing age and lower levels of education were associated with lower rates of a documented discussion. Hispanic patients, patients born outside the United States and those whose primary language was not English were less likely to actually receive reconstruction once the procedure was discussed

Based on these results, the study authors suggest that physicians should systematically address the issue of reconstruction with all patients undergoing mastectomy, including why she is or is not a candidate. They also recommend optimizing physician-patient discussions by using interpreters and appropriate educational materials to ensure an informative conversation regardless of primary language, ethnicity, or education level.


'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Related medicine news :

1. Family Discussion Plays Role in Breast Cancer Awareness
2. An Intimate Discussion on Health Care for Men
3. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
4. Harm of Abstinence-Only Programs in U.S. and Abroad Subject of Panel Discussion at Two Maine College Campuses
5. New Blog Provides Forum for Discussions on Supplement Safety
6. Early Detection Push from New Alzheimers Disease Discussion Group Points to Advances by Startup Companies, Including Louisville-Based Neuronetrix, Inc.
7. Finding the right words: Provider-patient discussions can help domestic violence victims speak up
8. Clarient CEO Andrews to Participate in Panel Discussion at the RBC Capital Markets 2007 Healthcare Conference
9. Air Products in Advanced Discussions With Wacker Over Polymers Business
10. Peak International Sets Time for Discussion of Second Quarter Fiscal 2008 Financial Results
11. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ... serving the families and businesses of the Norwalk and Vermillion areas, celebrates ... Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... owned and organized by HMP Communications Holdings, LLC, today announced that RestorixHealth® ... its nationwide network of wound centers interested in becoming Certified Wound Specialist Physicians ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... and workflow solutions, today named The Resource Group as their 2016 Microsoft Dynamics ... partner conference in Newport Beach, CA. The award recognizes The Resource Group ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... supplements that help improve all aspects of people’s health and nutrition, announced its ... nutritional products. , Natural Subsistence develops nutritional supplements that help people improve ...
(Date:3/23/2017)... ... March 23, 2017 , ... The Leaders ... life-altering and fatal diseases in opposition to the President’s Fiscal Year 2018 ... care, services, and hope for the most vulnerable among us. , The proposed ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)...  The U.S. Food and Drug Administration today granted ... adults and pediatric patients 12 years and older with ... not received prior chemotherapy. This is the first FDA-approved ... skin cancer. "While skin cancer is one ... form called Merkel cell cancer have not had an ...
(Date:3/23/2017)... and VANCOUVER, British Columbia , ... SPHS ) (the "Company" or "Sophiris"), a clinical ... of urological diseases, today announced that data from its ... drug as a focal treatment for localized prostate cancer, ... 2017 at the 32 nd Annual European Association ...
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... their offering. ... The global oxygen therapy devices market to grow at a CAGR ... Global Oxygen Therapy Devices Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Medicine Technology: